We show for the first time that Bcl-3 is present in a subset of MM patients, and that the high gene expression at the time of diagnosis is associated with inferior prognosis as demonstrated in a large cohort of newly diagnosed patients. The gene discussed is BCL3; the disease is Miyoshi myopathy.